Blog

May 21, 2024, 12:00

Michael Wang: Mechanisms of Senescence‑Associated Drug Resistance in Lymphoma

Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and Cellular Therapy at MD Anderson Cancer Center shared on X:

“A review in International Journal of Oncology discusses mechanisms of senescence‑associated drug resistance in lymphoma and highlights emerging strategies using senolytics, which are drugs designed to specifically target senescent cells.”

Read further.
Source: Michael Wang/X

cancer Cancer Treatment Strategies Cellular Therapy drug resistance mechanisms International Journal of Oncology lymphoma MD Anderson Cancer Center medical review Michael Wang Myeloma OncoDaily Oncology oncology research senescence-associated drug resistance senescent cells senolytics Stem Cell Transplantation

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage